| The Effectiveness of the LCP in Improving End of Life Care for Dying Cancer Patients in Hospital. (NCT01081899) | Regional Palliative Care Network | 2009-11-01 |
| A Study of MORAb-009 in Patients With Solid Tumor (NCT01018784) | Eisai Co., Ltd. | 2009-11-01 |
| Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients (NCT01017172) | Goethe University | 2009-11-01 |
| Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor (NCT01037127) | GlaxoSmithKline | 2009-11-01 |
| Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours (NCT00979134) | AstraZeneca | 2009-10-21 |
| Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients (NCT00983346) | University of Utah | 2009-10-01 |
| Care Partners: Web-based Support for Caregivers of Veterans Undergoing Chemotherapy (NCT00983892) | VA Office of Research and Development | 2009-10-01 |
| Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer (NCT00925899) | Bispebjerg Hospital | 2009-10-01 |
| Clinical Validation of a Microfluidic Device for Isolation and Molecular Characterization of Circulating Tumor Cells (NCT01022723) | National Cancer Centre, Singapore | 2009-10-01 |
| Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients (NCT00851448) | Fresenius Kabi | 2009-10-01 |
| Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention (NCT01305447) | University of Western Ontario, Canada | 2009-10-01 |
| A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma. (NCT00996567) | University Hospital, Ghent | 2009-10-01 |
| Squire's Quest! II: Implementation Intentions and Children's Fruit, Juice, and Vegetable (FJV) Consumption (NCT01004094) | Baylor College of Medicine | 2009-10-01 |
| Distress Thermometer Intervention Trial (NCT00960466) | University Hospitals Bristol and Weston NHS Foundation Trust | 2009-10-01 |
| Anticoagulation in Cancer Related Stroke (NCT02743052) | Samsung Medical Center | 2009-10-01 |
| Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients (NCT00999882) | AstraZeneca | 2009-10-01 |
| Energy Value of Macronutrients From Pistachio Nuts and Mechanisms of Nutrient Action (NCT00942695) | United States Department of Agriculture (USDA) | 2009-10-01 |
| Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer (NCT00420563) | Centre Oscar Lambret | 2009-09-25 |
| Investigation of Cisplatin-Related Kidney Toxicity (NCT00984035) | University of Chicago | 2009-09-22 |
| A Study of LY2801653 in Advanced Cancer (NCT01285037) | Eli Lilly and Company | 2009-09-09 |
| Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness (NCT01077414) | National Institutes of Health Clinical Center (CC) | 2009-09-04 |
| An Intervention to Improve Outcomes in Patients With Advanced Cancer (NCT01272024) | Yale University | 2009-09-01 |
| Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma (NCT00983541) | University of Utah | 2009-09-01 |
| Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer (NCT00996983) | National Cancer Institute, Naples | 2009-09-01 |
| Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years (NCT00994760) | Takeda | 2009-09-01 |
| CHOICES: Understanding Clinical Trials as a Treatment Option (NCT00983866) | Kaiser Permanente | 2009-09-01 |
| A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy (NCT00891761) | GlaxoSmithKline | 2009-09-01 |
| Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1) (NCT03676010) | Institut Bergonié | 2009-09-01 |
| Refining Information Technology Support for Genetics in Medicine (NCT01225978) | Brigham and Women's Hospital | 2009-09-01 |
| Study of Cabozantinib (XL184) in Adults With Advanced Malignancies (NCT00940225) | Exelixis | 2009-09-01 |
| A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects (NCT00955773) | GlaxoSmithKline | 2009-08-17 |
| A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors (NCT00858377) | Amgen | 2009-08-10 |
| Characterizing Lone Parenting: A Multi-institutional Pilot Study of the Perceptions of Support and Perceived Stress of Lone Parents of Children With Cancer (NCT00969579) | National Institute of Mental Health (NIMH) | 2009-08-06 |
| Study of MEDI-547 to Evaluate the Safety, Tolerability, and Biologic Activity of IV Administration in Subjects With Relapsed or Refractory Solid Tumors (NCT00796055) | MedImmune LLC | 2009-08-01 |
| Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy (NCT00836160) | AstraZeneca | 2009-08-01 |
| Tailored Intervention Protocol for Oral Chemotherapy Adherence (NCT00932490) | Duke University | 2009-08-01 |
| Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055 (NCT00973076) | AstraZeneca | 2009-08-01 |
| Motivational Interviewing for Physical Activity (NCT01008787) | M.D. Anderson Cancer Center | 2009-07-28 |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy (NCT00858364) | Amgen | 2009-07-17 |
| Facts and Attitudes About Clinical Trials (NCT01269645) | H. Lee Moffitt Cancer Center and Research Institute | 2009-07-01 |
| Adherence to Oral Anticancer Treatment Using Electronic Monitoring System (NCT01058044) | Centre Jean Perrin | 2009-07-01 |
| Exercise and Relaxation Intervention for Young Adult Cancer Survivors (NCT00801008) | The Miriam Hospital | 2009-07-01 |
| An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects (NCT00954291) | Taipei Medical University WanFang Hospital | 2009-07-01 |
| A Patient-Controlled Cognitive-Behavioral Intervention for Cancer Symptoms (NCT00946803) | University of Wisconsin, Madison | 2009-07-01 |
| Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors. (NCT00849550) | Herbert Hurwitz | 2009-07-01 |
| Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine (NCT00937664) | AstraZeneca | 2009-07-01 |
| A Phase I, Open-Label, First-Time-In-Human Study of the Oral AKT Inhibitor GSK2141795 (NCT00920257) | GlaxoSmithKline | 2009-06-16 |
| Reactions to Disease Risk Information (NCT00774254) | National Human Genome Research Institute (NHGRI) | 2009-06-16 |
| A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors (NCT00880321) | GlaxoSmithKline | 2009-06-04 |
| Drug Use Investigation for TYKERB Tablet (All Case Investigation) (NCT01332396) | Novartis | 2009-06-01 |
| Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans (NCT00925808) | M.D. Anderson Cancer Center | 2009-06-01 |
| Compression Anastomosis Using the Compression Anastomotic Ring-locking Procedure (CARP) (NCT01451008) | Region Skane | 2009-06-01 |
| Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers (NCT01079286) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2009-06-01 |
| Clinical Trial of Vitamin D3 to Reduce Cancer Risk in Postmenopausal Women (NCT01052051) | Creighton University | 2009-06-01 |
| Patient Communication Training Intervention (NCT00933855) | Memorial Sloan Kettering Cancer Center | 2009-06-01 |
| Bevacizumab and Vasoconstriction (NCT00929058) | Radboud University Medical Center | 2009-06-01 |
| Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments (NCT00920205) | Myrexis Inc. | 2009-06-01 |
| Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer (NCT00942968) | Pfizer | 2009-06-01 |
| Objective Flap Assessment During Reconstructive Surgery (NCT00952107) | Beth Israel Deaconess Medical Center | 2009-06-01 |
| Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (NCT00967148) | Ottawa Hospital Research Institute | 2009-06-01 |
| The Use of the ActiSight™ Needle Guidance System in Patients Undergoing CT-Guided With Lesions Smaller Than 15 mm (NCT01318473) | ActiViews Ltd. | 2009-06-01 |
| Breast Cancer With Over-expression of erbB2-BRAINSTORM (NCT01064349) | GlaxoSmithKline | 2009-05-06 |
| A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients (NCT00907166) | Cornerstone Pharmaceuticals | 2009-05-01 |
| Single-dose Escalation Trial of M2ES in Healthy Volunteer (NCT01223924) | Protgen Ltd | 2009-05-01 |
| Web-based Physical Activity Intervention for Young Adult Cancer Survivors (NCT00791375) | The Miriam Hospital | 2009-05-01 |
| Molecular-Genetic Correlates of Fatigue in Cancer Patients Receiving Localized External Beam Radiation Therapy (NCT00852111) | National Institute of Nursing Research (NINR) | 2009-04-23 |
| Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases (NCT01445483) | National Cancer Institute (NCI) | 2009-04-17 |
| 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates (NCT00886457) | Nevada Cancer Institute | 2009-04-01 |
| Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin (NCT01093690) | Mahidol University | 2009-04-01 |
| A Study for the Evaluation of the Safety, Tolerability, and Efficacy of ARX-F02 (Sufentanil NanoTab) Compared to Placebo in the Treatment of Cancer Breakthrough Pain (NCT00833040) | Talphera, Inc | 2009-04-01 |
| Pharmacogenetic DNA Bank (NCT00941200) | National University Hospital, Singapore | 2009-04-01 |
| Lapatinib in Combination With Vinorelbine (NCT01128543) | GlaxoSmithKline | 2009-04-01 |
| Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain (NCT01316744) | University of Glasgow | 2009-04-01 |
| A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients (NCT00876044) | Sanofi | 2009-04-01 |
| Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain (NCT00879775) | Korea Research Foundation | 2009-04-01 |
| Study of EC0489 for the Treatment of Refractory or Metastatic Tumors (NCT00852189) | Endocyte | 2009-04-01 |
| A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression (NCT00928382) | National Cancer Institute (NCI) | 2009-03-31 |
| A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma (NCT01065805) | AHS Cancer Control Alberta | 2009-03-20 |
| A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-573 in Subjects With Advanced Solid Tumors (NCT00816361) | MedImmune LLC | 2009-03-09 |
| Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer (NCT00807859) | Amgen | 2009-03-09 |
| A Dose Escalation, Dose Expansion Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575, in Subjects With Advanced Tumors. (NCT00816400) | MedImmune LLC | 2009-03-02 |
| A Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid Tumors (NCT00869895) | Eisai Inc. | 2009-03-01 |
| Analysis of Tokuhashi Score (NCT01210508) | State University of New York - Upstate Medical University | 2009-03-01 |
| Community Based Exercise Program for Well Cancer Survivors (NCT00798200) | Hamilton Health Sciences Corporation | 2009-03-01 |
| Femoral Bone Metastases (NCT01428895) | University Health Network, Toronto | 2009-03-01 |
| Identification and Treatment of Depression (NCT00863200) | M.D. Anderson Cancer Center | 2009-03-01 |
| Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate (NCT01046487) | Centre Oscar Lambret | 2009-02-09 |
| Psilocybin Cancer Anxiety Study (NCT00957359) | NYU Langone Health | 2009-02-01 |
| Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma (NCT00847522) | University of Utah | 2009-02-01 |
| Liver Function Test (LFT) Elevations in Cancer Patients and Users of Tyrosine Kinase Inhibitor (TKI) Drugs (NCT01098500) | GlaxoSmithKline | 2009-02-01 |
| Massage Therapy and Port-a-Catheter Insertion (NCT00991770) | Boston Medical Center | 2009-02-01 |
| Advanced MRI Sequences for Radiation Therapy Treatment Planning (NCT02340715) | Medical College of Wisconsin | 2009-02-01 |
| Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors (NCT01000376) | Eisai Limited | 2009-02-01 |
| Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients (NCT00716898) | Shaare Zedek Medical Center | 2009-02-01 |
| Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer (NCT00838201) | Amgen | 2009-02-01 |
| Traditional Chinese Medicine Five Elements Music Therapy Improving Quality of Life in Patients With Advanced Cancer (NCT00964314) | Ministry of Science and Technology of the People´s Republic of China | 2009-02-01 |
| Physical Activity in Public Housing - II (NCT00823498) | M.D. Anderson Cancer Center | 2009-01-13 |
| The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study (NCT00824278) | National Institute of Mental Health (NIMH) | 2009-01-13 |
| Disease Prevention in Clinical Practice Base on Patient Specific Physiology (NCT03308773) | Pacific Coast Family Medical Group | 2009-01-05 |
| FAmily CEntered (FACE) Advance Care Planning for Teens With Cancer (NCT01670461) | Maureen Lyon | 2009-01-01 |